Synergistic inhibition on acetylcholinesterase by the combination of berberine and palmatine originally isolated from Chinese medicinal herbs

Journal of Molecular Neuroscience

Volumn 53, Issue 3, 2014, Pages 511-516

  Mak, Shinghung ^a,b   Luk, Wilson W K ^a   Cui, Wei ^b,c   Hu, Shengquan ^b,c   Tsim, Karl W K ^a   Han, Yifan ^b,c  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^c The Hong Kong Polytechnic University   (Hong Kong)

Author keywords

Acetylcholinesterase inhibitor; Alkaloids; Alzheimer's disease; Berberine; Palmatine; Synergism

Indexed keywords

ACETYLCHOLINESTERASE; BERBERINE; PALMATINE; RECOMBINANT ENZYME; BERBERINE DERIVATIVE; CHOLINESTERASE INHIBITOR; HERBACEOUS AGENT;

ARTICLE; CHINESE HERB; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; ENZYME INHIBITION; HEK293 CELL LINE; HUMAN; METABOLISM;

ACETYLCHOLINESTERASE; BERBERINE; BERBERINE ALKALOIDS; CHOLINESTERASE INHIBITORS; DRUG SYNERGISM; DRUGS, CHINESE HERBAL; HEK293 CELLS; HUMANS;

EID: 84905013772     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-014-0288-5     Document Type: Article

References (31)

1. Ago Y, Koda K, Takuma K, Matsuda T (2011) Pharmacological aspects of the acetylcholinesterase inhibitor galantamine. J Pharmacol Sci 116:6-17
2. Bestas A, Goksu H, Erhan OL (2013) The effect of preoperative consumption of potatoes on succinylcholine-induced block and recovery from anesthesia. J Clin Monit Comput 27:609-612
3. Bi CW, Luk WK, Campanari ML et al (2014) Quantification of the transcripts encoding different forms of AChE in various cell types: real-time PCR coupled with standards in revealing the copy number. J Mol Neurosci (in press)
4. Choi RC, Zhu JT, Yung AW et al (2013) Synergistic action of flavonoids, baicalein, and daidzein in estrogenic and neuroprotective effects: a development of potential health products and therapeutic drugs against Alzheimer's disease. Evid Based Complement Alternat Med 2013:635694
5. Chou TC (2010) Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70:440-446
6. Chou TC, Motzer RJ, Tong Y, Bosl GJ (1994) Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design. J Natl Cancer Inst 86:1517-1524 (Pubitemid 24330215)
7. del Monte-Millan M, Garcia-Palomero E, Valenzuela R et al (2006) Dual binding site acetylcholinesterase inhibitors: potential new disease-modifying agents for AD. J Mol Neurosci 30:85-88
8. Dogterom P, Nagelkerke JF, Mulder GJ (1988) Hepatotoxicity of tetrahydroaminoacridine in isolated rat hepatocytes: effect of glutathione and vitamin E. Biochem Pharmacol 37:2311-2313
9. Dong TT, Zhao KJ, Gao QT et al (2006) Chemical and biological assessment of a Chinese herbal decoction containing Radix Astragali and Radix Angelicae Sinensis: determination of drug ratio in having optimized properties. J Agric Food Chem 54:2767-2774
10. Ellman GL, Courtney KD, Andres Jr V, Feather-Stone RM (1961) A new and rapid colorimetric detemination of acetylcholine activity. Biochem Pharmacol 7:88-95
11. Gao QT, Cheung JK, Li J et al (2007) A Chinese herbal decoction, Danggui Buxue Tang, activates extracellular signal-regulated kinase in cultured T-lymphocytes. FEBS Lett 581:5087-5093 (Pubitemid 47576090)
12. Han YF, Li CP, Chow E, Wang H, Pang YP, Carlier PR (1999) Dual-site binding of bivalent 4-aminopyridine- and 4-aminoquinoline-based AChE inhibitors: contribution of the hydrophobic alkylene tether to monomer and dimer affinities. Bioorg Med Chem 7:2569-2575 (Pubitemid 30122759)
13. Hopkins TJ, Rupprecht LE, Hayes MR, Blendy JA, Schmidt HD (2012) Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats. Neuropsychopharmacology 37:2310-2321
14. Huang L, Su T, Li X (2013) Natural products as sources of new lead compounds for the treatment of Alzheimer's disease. Curr Top Med Chem 13:1864-1878
15. Imanshahidi M, Hosseinzadeh H (2008) Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 22:999-1012
16. Konrath EL, Passos Cdos S, Klein LC Jr, Henriques AT (2013) Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease. J Pharm Pharmacol 65:1701-1725
17. Kupeli E, Kosar M, Yesilada E, Husnu K, Baser C (2002) A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species. Life Sci 72:645-657 (Pubitemid 35441232)
18. Li W, Xue J, Niu C et al (2007) Synergistic neuroprotection by bis(7)-tacrine via concurrent blockade of N-methyl-D-aspartate receptors and neuronal nitric-oxide synthase. Mol Pharmacol 71:1258-1267 (Pubitemid 46658679)
19. Lin HQ, Ho MT, Lau LS, Wong KK, Shaw PC, Wan DC (2008) Antiacetylcholinesterase activities of traditional Chinese medicine for treating Alzheimer's disease. Chem Biol Interact 175:352-354
20. Liu JP, Feng L, Zhang MH et al (2013) Neuroprotective effect of Liuwei Dihuang decoction on cognition deficits of diabetic encephalopathy in streptozotocin-induced diabetic rat. J Ethnopharmacol 150:371-381
21. Luk WK, Chen VP, Choi RC, Tsim KW (2012) N-linked glycosylation of dimeric acetylcholinesterase in erythrocytes is essential for enzyme maturation and membrane targeting. Febs J 279:3229-3239
22. Murray AP, Faraoni MB, Castro MJ, Alza NP, Cavallaro V (2013) Natural AChE inhibitors from plants and their contribution to Alzheimer's disease therapy. Curr Neuropharmacol 11:388-413
23. Ohnishi T, Sakiyama Y, Okuri Y et al (2013) The prediction of response to galantamine treatment in patientswith mild tomoderate Alzheimer's disease. Curr Alzheimer Res (in press)
24. Preissner S, Dunkel M, Hoffmann MF et al (2012) Drug cocktail optimization in chemotherapy of cancer. PLoS One 7:e51020
25. Schwarz M, Glick D, Loewenstein Y, Soreq H (1995) Engineering of human cholinesterases explains and predicts diverse consequences of administration of various drugs and poisons. Pharmacol Ther 67:283-322
26. Sun ZK, Yang HQ, Chen SD (2013) Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer's disease.Transl Neurodegener 2:6
27. Williams TL, Serpell LC (2011) Membrane and surface interactions of Alzheimer's Aβ peptide - insights into the mechanism of cytotoxicity. FEBS J 278:3905-3917
28. Xiao HT, Peng J, Liang Y et al (2011) Acetylcholinesterase inhibitors from Corydalis yanhusuo. Nat Prod Res 25:1418-1422
29. Ye M, Fu S, Pi R, He F (2009) Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research. J Pharm Pharmacol 61:831-837
30. Yi J, Ye X, Wang D et al (2013) Safety evaluation of main alkaloids from Rhizoma Coptidis. J Ethnopharmacol 145:303-310
31. Zhao LN, Long H, Mu Y, Chew LY (2012) The toxicity of amyloid β oligomers. Int J Mol Sci 13:7303-7327